Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2003
05/28/2003EP1313508A2 Combination containing an antifolate and methylmalonic acid lowering agent
05/28/2003EP1313507A2 Modulators of intermediate conductance calcium-activated potassium (ikca) channel activity for treating sexual dysfunction
05/28/2003EP1313501A2 Functions for dp214
05/28/2003EP1313500A2 Combinations of dalfopristine/quinupristine with cefpirome
05/28/2003EP1313498A2 Phospholipase d effectors for therapy and screening
05/28/2003EP1313496A1 Use of a composition comprising an extract of pollen for the treatment of edema
05/28/2003EP1313495A1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders
05/28/2003EP1313494A1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain
05/28/2003EP1313493A1 Use of a composition comprising an extract of pollen for the treatment of irritability
05/28/2003EP1313492A1 Use of a composition comprising an extract of pollen for the treatment of dysphoria
05/28/2003EP1313490A1 Pharmaceutical composition comprising wikstromol and/or matairesinol, its use as hepatoprotectant and process for their isolation from cedrus deodara
05/28/2003EP1313489A2 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
05/28/2003EP1313488A1 Compositions and methods for improving cardiovascular function
05/28/2003EP1313487A1 Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof
05/28/2003EP1313485A2 Use of an aldosterone receptor antagonist to improve cognitive function
05/28/2003EP1313484A2 Pharmaceutical formulation of salmeterol and fluticasone propionate
05/28/2003EP1313483A2 Methods for inducing apolipoprotein e secretion
05/28/2003EP1313482A1 Pharmaceutical composition and method for treating hypogonadism
05/28/2003EP1313481A1 Pharmaceutical composition comprising condensed indole compound
05/28/2003EP1313480A2 Use of an arylaldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer
05/28/2003EP1313479A1 Hair loss prevention
05/28/2003EP1313478A2 Method for treatment of migraine using pde5 inhibitors
05/28/2003EP1313476A2 Sgk2 and sgk3 used as diagnostic and therapeutic targets
05/28/2003EP1313475A1 Anti-cancer composition composed of anti-cancer and anti-malarial drugs
05/28/2003EP1313474A2 Paroxetine compositions and processes for making the same
05/28/2003EP1313473A2 Sustained release formulations for growth hormone secretagogues
05/28/2003EP1313472A1 Method for reducing or eliminating smoking
05/28/2003EP1313471A1 Benzylidene thiazolidinediones and their use as antimycotic agents
05/28/2003EP1313470A1 Novel alicyclic imidazoles as h 3 agents
05/28/2003EP1313469A1 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections
05/28/2003EP1313468A2 Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors
05/28/2003EP1313467A2 Novel pharmaceutical composition for administering n-0923
05/28/2003EP1313466A1 Bimodal emulsions of taxanes and butyrate polyalcohol esters
05/28/2003EP1313465A1 Composition and method for treatment of hypertriglyceridemia
05/28/2003EP1313464A2 Method for treatment of reactive arthritis or bursitis
05/28/2003EP1313463A1 Fatty acid analogues for the treatment of cancer
05/28/2003EP1313462A1 Use of asiatic acid or asiaticoside for treatment of cancer
05/28/2003EP1313461A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
05/28/2003EP1313460A2 Therapeutic use and formulation of (-)-tramadol
05/28/2003EP1313459A1 Polycyclic dianthraquinones as anti-cancer and anti-angiogenic agents
05/28/2003EP1313457A1 Transdermal therapeutic system for releasing venlafaxine
05/28/2003EP1313456A2 Intradermal-penetration agents for topical local anesthetic administration
05/28/2003EP1313453A1 Particulate vectors for improving oral absorption of active principles
05/28/2003EP1313449A2 Amphotericin b structured emulsion
05/28/2003EP1313448A1 Topical aminolevulinic acid-photodynamic therapy for acne vulgaris
05/28/2003EP1313447A1 Palatable oral coenzyme q liquid
05/28/2003EP1313442A2 Storage stable tretinoin and 4-hydroxy anisole containing topical composition
05/28/2003EP1313426A4 Succinoylamino benzodiazepines as inhibitors of a-beta protein production
05/28/2003EP1313426A2 Succinoylamino benzodiazepines as inhibitors of a-beta protein production
05/28/2003EP1313422A1 Non-hormonal vaginal contraceptive
05/28/2003EP1313379A2 Alpha-(1,4)linked glucose polymers containing oral compositions to alleviate or prevent tooth damage
05/28/2003EP1313377A2 Treatment of helicobacter with isothiocyanates
05/28/2003EP1278412A4 Polymer conjugates of ara-c and ara-c derivatives
05/28/2003EP1244439A4 Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage
05/28/2003EP1232173B1 Fusidic acid derivatives
05/28/2003EP1231211B1 Thiazolidinedione derivatives as antidiabetic agents
05/28/2003EP1212313B1 7-carboxy-flavone derivatives, preparation method and therapeutic use
05/28/2003EP1206462B1 Heterocyclic compounds inhibiting angiogenesis
05/28/2003EP1189903B1 Novel benzo[f]naphthyridine, preparation and compositions containing them
05/28/2003EP1175149B9 Disinfecting composition based on h2o2, acids and metal ions
05/28/2003EP1169300B1 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof
05/28/2003EP1165108B1 Use of a serenoa repens extract for the production of a medicament to treat prostate cancer
05/28/2003EP1163239B1 Modified amino-acid amides as cgrp antagonists
05/28/2003EP1161428B1 Pyrimidine compounds
05/28/2003EP1150988B1 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
05/28/2003EP1150664B1 Novel use of orexin receptor antagonists
05/28/2003EP1146884A4 Novel polymer formulations containing perfluorinated compounds for the engineering of cells and tissues for transplantation that improves cell metabolism and survival, and methods for making same
05/28/2003EP1146865B1 Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol
05/28/2003EP1143945B1 Carnitine supplemented diet to prevent sudden death syndrome in broiler breeder type poultry
05/28/2003EP1140188B1 Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
05/28/2003EP1140035B1 Method for preparing an effervescent granulate comprising iron gluconate, granulate thus obtained and tablets containing the same
05/28/2003EP1128810B1 Drug delivery device, especially for the delivery of androgens
05/28/2003EP1124842B1 Betulinic acid derivatives useful for the treatment of neuroectodermal tumors
05/28/2003EP1115478A4 Emollient esters based upon capryl alcohol and isostearic acid
05/28/2003EP1107749B1 Fumaric acid derivatives for the treatment of transplant rejection
05/28/2003EP1105114B1 Nimesulide containing topical pharmaceutical compositions
05/28/2003EP1100777B1 Sulfurated distamycin derivatives, process for preparing them, and their use as antitumor agents
05/28/2003EP1097145B1 Polyhydroalkylpyrazine derivatives and their preparation and medicines containing them
05/28/2003EP1070077B1 15-membered lactams ketolides with antibacterial activity
05/28/2003EP1068198B1 5-heteroaryl substituted indoles
05/28/2003EP1067916B1 Method for producing transdermal therapeutic systems by using basic alkali metal salts for converting active agent salts into free bases
05/28/2003EP1056358B1 Use of d-tagatose as a prebiotic food component
05/28/2003EP1054678B1 Combination of steroid and polyunsaturated fatty acids for treatment of inflammatory conditions
05/28/2003EP1049706B1 New pentasaccharides, their methods of production and pharmaceutical compositions containing same
05/28/2003EP1039904B1 Synergistic antimicrobial compositions
05/28/2003EP1032415B1 Composition for the treatment of allergic conditions with cysteine and serine proteinase inhibitors
05/28/2003EP1015444B1 Pyrimidine derivatives and processes for the preparation thereof
05/28/2003EP1014996B1 Saccharide-containing compositions for treating alzheimer's disease and other amyloidoses
05/28/2003EP1011682B1 Hormonal contraceptive
05/28/2003EP0981358B1 Dolastatin-15 derivatives in combination with taxanes
05/28/2003EP0973763B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
05/28/2003EP0971713B1 Use of cholinesterase inhibitors to treat disorders of attention
05/28/2003EP0969833B1 Extension of the expression of transgenic proteins by immunomodulation with 15-deoxyspergualine with 15-deoxyspergualine
05/28/2003EP0966464B1 Substituted 2,4-diaminopyrimidines
05/28/2003EP0956027B1 Semi-synthetic sulphaminoheparosansulphates having high anti-metastatic activity and reduced haemorrhagic risk
05/28/2003EP0941253B1 New butyric esters with antiproliferative activity and the pharmaceutical compositions containing them
05/28/2003EP0941100B1 Pharmaceutical compositions containing lamivudine and zidovudine
05/28/2003EP0934061B1 Isobutylgaba and its derivatives for the treatment of pain
05/28/2003EP0928294B1 Method and apparatus for preparing an acellular red blood cell substitute
05/28/2003EP0918517B1 Composition of micro-organisms containing omega-3-fatty acid useful as a prophylactic or therapeutic agent against coccidiosis of animals
1 ... 5455 5456 5457 5458 5459 5460 5461 5462 5463 5464 5465 5466 5467 5468 5469 5470 5471 5472 5473 5474 5475 ... 7860